-
Mashup Score: 22Episode 50. Quadruplets in Newly Diagnosed Transplant-Ineligible Myeloma with Dr. Timothy Schmidt | Blood Cancer Talks | Episode 51 - 3 month(s) ago
In this episode, we discuss the management of newly diagnosed transplant in-eligible multiple myeloma with Dr. Timothy Schmidt, with a special focus on IMROZ and BENEFIT RCTs testing quadruplets in this space.ย Here are the key papers we discussed:ย 1. MAIA trial…
Source: share.transistor.fmCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 18Episode 49. Updates on Low-Risk MDS with Dr. Maximilian Stahl | Blood Cancer Talks | Episode 50 - 3 month(s) ago
In this episode, we discuss updates on low-risk MDS with Dr. Maximilian Stahl with a focus on imetelstat and luspatercept.ย Here are the trials we discussed:ย 1. IWG 2019 response criteriahttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042664/ย 2. MEDALIST trial:…
Source: share.transistor.fmCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 46Episode 47. ASCO/EHA 2024 Lymphoma Updates with Dr. Gloria Iacoboni | Blood Cancer Talks | Episode 48 - 4 month(s) ago
In this episode, we reviewed the hottest updates in lymphoma from ASCO and EHA 2024, held in Chicago and Madrid respectively, with Dr. Gloria Iacoboni, a haematologist from University Hospital Vall d’Hebron, in Barcelona, Spain. Here are the key abstracts we discussed:ย 1.ย ย ย STARGLO:…
Source: share.transistor.fmCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 22Episode 46. Updates in Myeloma MRD with Dr. Ben Derman and Dr. Manni Mohyuddin | Blood Cancer Talks | Episode 47 - 5 month(s) ago
In this episode, we dive into updates in Minimal Residual Disease (MRD) in multiple myeloma, along with the FDA ODAC meeting in April 2024 to decide on MRD as a surrogate endpoint for accelerated approval. Our guests are Dr. Benjamin Derman and Dr. Manni Mohyuddin. Here are the key papers we…
Source: share.transistor.fmCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 25Episode 42. CAR T-cell Therapy in Early Relapsed Myeloma with Dr. Samer Al Hadidi | Blood Cancer Talks | Episode 43 - 8 month(s) ago
In this episode, we talked about overall survival data from CARTITUDE-4 and KarMMa-3 that was presented at FDA ODAC meeting with Dr. Samer Al Hadidi from University of Arkansas Myeloma Center.ย RCTs of BCMA CAR T-cell Therapy in Early Relapsed Multiple Myeloma:a) KarMMa-3 (ide-cel):…
Source: share.transistor.fmCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 34Episode 40. Management of Newly Diagnosed AL Amyloidosis | Blood Cancer Talks | Episode 41 - 9 month(s) ago
In this episode we discuss the management of newly diagnosed AL amyloidosis with Dr. Angela Dispenzieri from the Mayo Clinic.ย Here are the key articles discussed:1.ย ย ย Optimal use of tissue biopsy in AL amyloidosis: https://pubmed.ncbi.nlm.nih.gov/28271734/ย 2.ย ย ย Mayo 2004 staging:ย …
Source: share.transistor.fmCategories: General Medicine News, Partners & KOLsTweet-
Tune in to our new episode on management of AL Amyloidosis with @ADispenzieri! We dive into the nuances of management including tissue biopsy, risk stratification, monitoring patients while on Dara-VCD, and many more critical issues! https://t.co/qH9gsov1p5 Check out this clip: https://t.co/gnMRfBAu1s
-
-
Mashup Score: 30โBlood Cancer Talks: Episode 38. ASH 2023 Leukemia and Myeloid Neoplasm Recap with Dr. Anand Patel on Apple Podcasts - 9 month(s) ago
โShow Blood Cancer Talks, Ep Episode 38. ASH 2023 Leukemia and Myeloid Neoplasm Recap with Dr. Anand Patel – Feb 8, 2024
Source: comsync.lijit.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 41โBlood Cancer Talks: Episode 38. GVHD Prophylaxis in Allo-Transplant with Dr. Shernan Holtan on Apple Podcasts - 10 month(s) ago
โShow Blood Cancer Talks, Ep Episode 38. GVHD Prophylaxis in Allo-Transplant with Dr. Shernan Holtan – Jan 19, 2024
Source: podcasts.apple.comCategories: General Medicine News, Partners & KOLsTweet-
๐ฅOur latest episode on GVHD ppx in allo-transplant with @sghmd! As @sghmd says, "๐ฐ๐ ๐ฐ๐๐ง๐ญ ๐ญ๐จ ๐๐จ ๐๐ฏ๐๐ซ๐ฒ๐ญ๐ก๐ข๐ง๐ ๐ฐ๐ ๐๐๐ง ๐ญ๐จ ๐๐ฏ๐จ๐ข๐ ๐ ๐ข๐ฏ๐ข๐ง๐ ๐ก๐ข๐ ๐ก ๐๐จ๐ฌ๐ ๐ฌ๐ญ๐๐ซ๐จ๐ข๐๐ฌ"! ๐Clip on BMT CTN 1203 and GRFS endpoint! https://t.co/cgCgucGqU3 https://t.co/MMI0Y8WtQb
-
-
Mashup Score: 39Episode 37. ASH 2023 Myeloma Recap with Dr. Ben Derman | Blood Cancer Talks | Episode 38 - 11 month(s) ago
In this episode, we discuss the key abstracts in myeloma and related plasma cell disorders at ASH23 with Dr. Benjamin Derman. Here are the abstracts discussed in this episode:ย First, we will focus on a few abstracts in precursor states, MGUS.ย 1.ย ย ย New diagnostic criteria for light chain MGUS…
Source: share.transistor.fmCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 8โBlood Cancer Talks: Episode 26. Management of Newly Diagnosed Hodgkin's Lymphoma on Apple Podcasts - 11 month(s) ago
โShow Blood Cancer Talks, Ep Episode 26. Management of Newly Diagnosed Hodgkin’s Lymphoma – Jul 15, 2023
Source: podcasts.apple.comCategories: General Medicine News, Partners & KOLsTweet-
๐Our top downloaded episode of 2023 featured the brilliant Dr. Nancy Bartlett discussing Hodgkin lymphoma! ๐๏ธDelve into her insightful analysis of pivotal trials, where she skillfully navigates the delicate balance between enthusiasm and skepticism #lymsm https://t.co/VahbHn08Hc https://t.co/ynKVU6hYLW
-
Tune in to our new episode on quadruplets in newly diagnosed transplant-ineligible #Myeloma with @TMSchmidtMD! ๐๏ธ We break down the IMROZ & BENEFIT trials and how to apply them in our current practice. ๐ฉบ๐ https://t.co/llyKn6PmpW Check out this short clip! https://t.co/GX8So3HWCe